Core Viewpoint - The company, Hema Medical (03309), announced the acquisition of 58% of the issued share capital of Hong Kong Endoscopy Centre Limited, which will become a subsidiary upon completion of the acquisition expected around October 2025 [1] Group 1: Acquisition Details - The acquisition agreement was signed with three individual sellers on August 26, 2025 [1] - Hong Kong Endoscopy Centre, established in 2016, operates three endoscopy examination rooms and provides specialized medical services including gastroscopy, colonoscopy, and cystoscopy [1] - The acquisition is anticipated to enhance the company's medical service offerings in Hong Kong and leverage existing patient bases for synergistic effects with its operations in Shenzhen [1] Group 2: Strategic Rationale - The company aims to meet the market demand for high-quality medical services and has been actively exploring potential business opportunities [1] - The board believes that Hong Kong Endoscopy Centre possesses advantages in management, quality medical services, and financial performance, making the acquisition beneficial for the company and its shareholders [1]

钛媒体App 8月22日消息，通策医疗(600763.SH)公告称，全资子公司通策口腔投资收购上海存济口腔门 诊部99%股权，杭州通盛医疗投资管理有限公司收购其1%股权，交易总金额为4600万元。标的公司为 上海通策口腔医院有限公司全资子公司，本次交易构成关联交易。公司表示，本次收购将提升品牌在高 端市场的辐射力与知名度，优化业务区域布局和产品服务结构。（公司公告） ...

Core Viewpoint - Tongce Medical announced the acquisition of a 99% stake in Shanghai Cunjie Dental Clinic for a total transaction amount of 46 million yuan, constituting a related party transaction [1] Group 1 - The acquisition was made by Tongce Medical's wholly-owned subsidiary, Zhejiang Tongce Dental Hospital Investment Management Group Co., Ltd. [1] - The remaining 1% stake in the target company was acquired by another wholly-owned subsidiary, Hangzhou Tongsheng Medical Investment Management Co., Ltd. [1] - The target company is a wholly-owned subsidiary of Shanghai Tongce Dental Hospital Co., Ltd., with the actual controller being the legal representative, Lv Jianming [1]